Riyadh to host global biotech leaders for RGMBS 2026

Riyadh will host the fourth Riyadh Global Medical Biotechnology Summit from Sept. 14-16, 2026, bringing together more than 100 speakers and delegates from over 70 countries. The event is positioned as a key showcase for Saudi Arabia’s push to build a biotech ecosystem, attract investment and advance its national biotech strategy.

Why it matters: - RGMBS 2026 is designed to help Saudi Arabia advance its National Biotechnology Strategy and its target of $34.6 billion in non-oil GDP from biotechnology by 2040. - The summit is meant to connect research, investment, regulation and manufacturing across the biotechnology value chain. - Saudi Arabia is using the event to present Riyadh as a regional and global hub for biotech innovation, talent and capital.

What happened: - The fourth Riyadh Global Medical Biotechnology Summit will take place in Riyadh from Sept. 14-16, 2026. - The summit expects more than 15,000 visitors, more than 100 local and international speakers, 200 biotech and health brands, and more than 80 government and industry exhibitors. - Delegations from more than 70 countries are expected. - Organizers are targeting more than 65 agreements and memorandums of understanding over three days. - Registration is open for delegates, exhibitors and industry partners. - Event details, the full scientific program and speaker list are available on the event website.

The details: - The summit will center on six themes: artificial intelligence in biotechnology, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and workforce development. - The scientific program spans the biomedical innovation pipeline, from population-scale genomics and AI-driven drug discovery to domestic biomanufacturing, regulatory science, commercialization and investment. - The event will include scientific sessions, panel discussions, workshops and agreement signings. - International delegates will be shown Saudi Arabia’s regulatory frameworks, manufacturing infrastructure and translational research capabilities. - The summit is held under the supervision of the Ministry of National Guard Health Affairs. - The event is hosted by King Abdullah International Medical Research Center and King Saud bin Abdulaziz University for Health Sciences. - The Ministry of Investment, Invest Saudi and the Saudi Data and AI Authority are strategic partners. - The summit is aligned with the kingdom’s broader effort to build biotech capacity across research, cGMP manufacturing and regulatory infrastructure.

Between the lines: - Saudi Arabia is signaling that biotech growth will depend on building foundational infrastructure, not only on bringing in global names and headline partnerships. - The summit message emphasizes ecosystem depth, with a focus on labs, clinical trial networks, biomanufacturing and digital platforms that can move research into practical use. - The event also highlights talent development as a core policy goal, not just a supporting element. - Named partnerships with Harvard University in translational oncology, AstraZeneca in gene therapy and Peking University in drug research are being used to show international credibility.

What's next: - Organizers expect speakers, exhibitors and delegations to finalize deals and partnerships during the Sept. 14-16 summit. - The event is expected to serve as a progress checkpoint for Saudi Arabia’s biotech strategy ahead of longer-term industrial and research buildout. - Follow updates using #RGMBS2026.

The bottom line: - RGMBS 2026 is both a biotech conference and a national industrial policy showcase, with Riyadh positioned as the center of Saudi Arabia’s bid to build a full-stack biotech ecosystem.